Drug application

QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)

Drugs@FDA ANDA 211405 · AMNEAL PHARMS

Key facts

Drug name QUETIAPINE FUMARATE
Active ingredients QUETIAPINE FUMARATE
Application type ANDA
Application number 211405
Company AMNEAL PHARMS
Dosage forms TABLET, EXTENDED RELEASE, ORAL
Strength EQ 400MG BASE
Marketing status Discontinued
Reference listed drug No
Latest submission status date Oct 26, 2018

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications